In today’s wrapup of technology headlines from other publications that affect the Triangle’s tech community:

  • Lenovo weighs raising prices after Brexit
  • SAS fails to win an injunction in a big court fight
  • An opioid decision helps BDSI
  • Quintiles launches a mobile glucose monitoring service
  • Duke Energy gears up its drone program

The details:

  • Bloomberg: Lenovo Considers Price Hikes, Other Measures to Tackle Brexit

Lenovo may hike prices after Britain’s Brexit vote, reports Bloomberg news.

“Lenovo will take the steps required to maintain profitability, Chief Financial Officer Wai Ming Wong said after the company’s annual general meeting Thursday. Asked if this would include job cuts in the region, he said that was among several options but wouldn’t go into specifics,” the wire service reports.

See details at:

  • News & Observer: SAS fails to win injunction against rival in $79M case

SAS has not been able to get an injunction against a rival even though it won a $79 million verdict in the case last year.

“Judge David A. Faber in New Bern recently denied SAS’s request for a permanent injunction that would have barred World Programming from selling its World Programming System, or WPS, software to U.S. business customers,” David Ranii reports..

Read the details at:

  • TBJ: Obama Administration decision boosts BDSI

New rules on opioid pain killers announced Wednesday helped Raleigh’s BioDelivery Sciences International, reports the Triangle Business Journal.

“Investors in Raleigh-based drug developer BioDelivery Sciences International saw the new rules as a good opportunity for the company and traded shares up as much as 20 percent in the morning. Shares fell back in the late morning, but still traded ahead of Tuesday’s close,” the newspaper says.

Read the story at:

  • Durham herald Sun: Quintiles launches glucose monitoring service for diabetics

Quintiles’ mobile health initiatives now includes glucose monitoring.

“This new solution combines wearable technology with Quintiles’ therapeutic and analytical systems to help enhance the efficiency and quality of diabetes-focused clinical trials,” the Herald Sun reports.

Read more at:

  • TBJ: Duke Energy’s drone strategy moves forward

Duke Energy is moving to capitalize on new federal rules for commercial use of drones.

“Aleksander Vukojevic, Duke’s technology development manager, says that while the company has been testing ways to use the devices for about two years, it’s coming close to implementing a wider-scale deployment of the technology,” says the Triangle Business Journal.

Read more at: